BartnykaitÄ—, A.; SavukaitytÄ—, A.; BekampytÄ—, J.; UgenskienÄ—, R.; LaukaitienÄ—, D.; Korobeinikova, E.; GudaitienÄ—, J.; JuozaitytÄ—, E.
The Role of Matrix Metalloproteinase Single-Nucleotide Polymorphisms in the Clinicopathological Properties of Breast Cancer. Biomedicines 2022, 10, 1891.
https://doi.org/10.3390/biomedicines10081891
AMA Style
BartnykaitÄ— A, SavukaitytÄ— A, BekampytÄ— J, UgenskienÄ— R, LaukaitienÄ— D, Korobeinikova E, GudaitienÄ— J, JuozaitytÄ— E.
The Role of Matrix Metalloproteinase Single-Nucleotide Polymorphisms in the Clinicopathological Properties of Breast Cancer. Biomedicines. 2022; 10(8):1891.
https://doi.org/10.3390/biomedicines10081891
Chicago/Turabian Style
BartnykaitÄ—, AgnÄ—, AistÄ— SavukaitytÄ—, Justina BekampytÄ—, Rasa UgenskienÄ—, DanguolÄ— LaukaitienÄ—, Erika Korobeinikova, Jurgita GudaitienÄ—, and Elona JuozaitytÄ—.
2022. "The Role of Matrix Metalloproteinase Single-Nucleotide Polymorphisms in the Clinicopathological Properties of Breast Cancer" Biomedicines 10, no. 8: 1891.
https://doi.org/10.3390/biomedicines10081891
APA Style
BartnykaitÄ—, A., SavukaitytÄ—, A., BekampytÄ—, J., UgenskienÄ—, R., LaukaitienÄ—, D., Korobeinikova, E., GudaitienÄ—, J., & JuozaitytÄ—, E.
(2022). The Role of Matrix Metalloproteinase Single-Nucleotide Polymorphisms in the Clinicopathological Properties of Breast Cancer. Biomedicines, 10(8), 1891.
https://doi.org/10.3390/biomedicines10081891